Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912462653> ?p ?o ?g. }
- W2912462653 abstract "Cancer vaccines and oncolytic immunotherapy are promising treatment strategies with potential to provide greater clinical benefit to patients with advanced-stage cancer. In particular, recombinant vaccinia viruses (VV) hold great promise as interventional agents. In this article, we first summarize the current understanding of virus biology and viral genes involved in host-virus interactions to further improve the utility of these agents in therapeutic applications. We then discuss recent findings from basic and clinical studies using VV as cancer vaccines and oncolytic immunotherapies. Despite encouraging results gleaned from translational studies in animal models, clinical trials implementing VV vectors alone as cancer vaccines have yielded largely disappointing results. However, the combination of VV vaccines with alternate forms of standard therapies has resulted in superior clinical efficacy. For instance, combination regimens using TG4010 (MVA-MUC1-IL2) with first-line chemotherapy in advanced-stage non-small cell lung cancer or combining PANVAC with docetaxel in the setting of metastatic breast cancer have clearly provided enhanced clinical benefits to patients. Another novel cancer vaccine approach is to stimulate anti-tumor immunity via STING activation in Batf3-dependent dendritic cells (DC) through the use of replication-attenuated VV vectors. Oncolytic VVs have now been engineered for improved safety and superior therapeutic efficacy by arming them with immune-stimulatory genes or pro-apoptotic molecules to facilitate tumor immunogenic cell death, leading to enhanced DC-mediated cross-priming of T cells recognizing tumor antigens, including neoantigens. Encouraging translational and early phase clinical results with Pexa-Vec have matured into an ongoing global phase III trial for patients with hepatocellular carcinoma. Combinatorial approaches, most notably those using immune checkpoint blockade, have produced exciting pre-clinical results and warrant the development of innovative clinical studies. Finally, we discuss major hurdles that remain in the field and offer some perspectives regarding the development of next generation VV vectors for use as cancer therapeutics." @default.
- W2912462653 created "2019-02-21" @default.
- W2912462653 creator A5007616348 @default.
- W2912462653 creator A5026230747 @default.
- W2912462653 creator A5037212511 @default.
- W2912462653 creator A5044395307 @default.
- W2912462653 creator A5051030840 @default.
- W2912462653 creator A5054335657 @default.
- W2912462653 creator A5072580005 @default.
- W2912462653 creator A5074690786 @default.
- W2912462653 creator A5078625617 @default.
- W2912462653 creator A5082140456 @default.
- W2912462653 creator A5082293320 @default.
- W2912462653 date "2019-01-09" @default.
- W2912462653 modified "2023-10-15" @default.
- W2912462653 title "Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics" @default.
- W2912462653 cites W103004725 @default.
- W2912462653 cites W1492732274 @default.
- W2912462653 cites W1514587909 @default.
- W2912462653 cites W1539039043 @default.
- W2912462653 cites W1562244424 @default.
- W2912462653 cites W1562702833 @default.
- W2912462653 cites W1564332803 @default.
- W2912462653 cites W1587652097 @default.
- W2912462653 cites W1593420214 @default.
- W2912462653 cites W1616543567 @default.
- W2912462653 cites W1650055942 @default.
- W2912462653 cites W1761567681 @default.
- W2912462653 cites W1921973844 @default.
- W2912462653 cites W1938515409 @default.
- W2912462653 cites W1950362618 @default.
- W2912462653 cites W1964056896 @default.
- W2912462653 cites W1965497380 @default.
- W2912462653 cites W1966510211 @default.
- W2912462653 cites W1967262248 @default.
- W2912462653 cites W1968263831 @default.
- W2912462653 cites W1972762291 @default.
- W2912462653 cites W1975739500 @default.
- W2912462653 cites W1976777395 @default.
- W2912462653 cites W1977061115 @default.
- W2912462653 cites W1980591752 @default.
- W2912462653 cites W1984484036 @default.
- W2912462653 cites W1987571005 @default.
- W2912462653 cites W1989186015 @default.
- W2912462653 cites W1989569988 @default.
- W2912462653 cites W1989893709 @default.
- W2912462653 cites W1990832903 @default.
- W2912462653 cites W1992974476 @default.
- W2912462653 cites W1996445525 @default.
- W2912462653 cites W1996479902 @default.
- W2912462653 cites W1998933123 @default.
- W2912462653 cites W2001075274 @default.
- W2912462653 cites W2002293894 @default.
- W2912462653 cites W2003702834 @default.
- W2912462653 cites W2007818370 @default.
- W2912462653 cites W2009720434 @default.
- W2912462653 cites W2011291060 @default.
- W2912462653 cites W2011458181 @default.
- W2912462653 cites W2020009024 @default.
- W2912462653 cites W2020849247 @default.
- W2912462653 cites W2022636281 @default.
- W2912462653 cites W2027434594 @default.
- W2912462653 cites W2042019209 @default.
- W2912462653 cites W2043889392 @default.
- W2912462653 cites W2045483305 @default.
- W2912462653 cites W2045920958 @default.
- W2912462653 cites W2047805526 @default.
- W2912462653 cites W2053453146 @default.
- W2912462653 cites W2055661097 @default.
- W2912462653 cites W2057111361 @default.
- W2912462653 cites W2058025467 @default.
- W2912462653 cites W2058655889 @default.
- W2912462653 cites W2071193341 @default.
- W2912462653 cites W2072730267 @default.
- W2912462653 cites W2073280587 @default.
- W2912462653 cites W2075631864 @default.
- W2912462653 cites W2076674654 @default.
- W2912462653 cites W2076761426 @default.
- W2912462653 cites W2083157454 @default.
- W2912462653 cites W2084905482 @default.
- W2912462653 cites W2091381558 @default.
- W2912462653 cites W2092018061 @default.
- W2912462653 cites W2093059993 @default.
- W2912462653 cites W2093291656 @default.
- W2912462653 cites W2095362431 @default.
- W2912462653 cites W2095927984 @default.
- W2912462653 cites W2096825083 @default.
- W2912462653 cites W2097047387 @default.
- W2912462653 cites W2097225513 @default.
- W2912462653 cites W2097849707 @default.
- W2912462653 cites W2098364796 @default.
- W2912462653 cites W2098500718 @default.
- W2912462653 cites W2098574945 @default.
- W2912462653 cites W2100342970 @default.
- W2912462653 cites W2100455637 @default.
- W2912462653 cites W2104955866 @default.
- W2912462653 cites W2107069570 @default.
- W2912462653 cites W2107106395 @default.
- W2912462653 cites W2108595427 @default.
- W2912462653 cites W2108883303 @default.